Novel SARS-CoV-2/COVID-19: Origin, pathogenesis, genes and genetic variations, immune responses and phylogenetic

Yasmeen Junejo1, Mehmet Ozaslan2, Muhamad Safdar2,3

  • 1Department of Physiology and Biochemistry, Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan.

Gene Reports
|June 23, 2020
PubMed

Insights

This review examines Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) origins, pathogenesis, and immune responses. It summarizes strategies for developing effective COVID-19 preventions and vaccines.

Area of Science:

  • Virology and Immunology
  • Epidemiology
  • Public Health

Background:

  • The emergence of SARS-CoV-2 in late 2019 led to the COVID-19 pandemic, causing widespread chaos and significant mortality.
  • The virus rapidly spread globally, declared a Public Health Emergency by the WHO, affecting over 210 countries.
  • As of June 3, 2020, there were over 6.4 million confirmed cases and 382,000 deaths worldwide.

Purpose of the Study:

  • To review the origins, pathogenesis, immune responses, and genetic characteristics of SARS-CoV-2.
  • To explore phylogenetic analyses and potential therapeutic strategies against COVID-19.
  • To summarize approaches for developing broadly effective preventions and vaccines for coronavirus infections.

Main Methods:

  • Comprehensive literature review focusing on SARS-CoV-2.
  • Analysis of existing data on viral origins, pathogenesis, and host immune responses.
  • Examination of genetic variations and phylogenetic studies.
  • Evaluation of current and proposed therapeutic and vaccine development strategies.

Main Results:

  • Detailed examination of SARS-CoV-2 origins and its relationship to other coronaviruses.
  • Understanding of the pathogenesis and host immune system's reaction to the virus.
  • Identification of key genes and genetic variations influencing viral behavior.
  • Overview of phylogenetic analyses to track viral evolution and spread.

Conclusions:

  • There is an urgent need for clinically approved vaccines and antiviral drugs for both new and existing coronavirus infections.
  • Developing effective, broadly applicable therapeutic and preventive strategies is crucial to combat current and future coronavirus outbreaks.
  • Further research into SARS-CoV-2 biology and immunology is essential for robust countermeasure development.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.4K
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
25.5K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.7K
Evolutionary Relationships through Genome Comparisons02:54

Evolutionary Relationships through Genome Comparisons

Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
6.7K
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
8.9K